// company-profile
Acrivon Therapeutics, Inc.
ACRV// activity-summary
Recent insider activity is bullish. Over the last 30 days, 7 insiders purchased shares. Buying was led by TOMSICEK MICHAEL JOHN.
// 90-day insight
Over the last 90 days, Acrivon Therapeutics, Inc. insiders bought $7.0M (23 transactions) and sold $31K (8 transactions).
- Most active insider: Blume-Jensen Peter with 5 transactions totaling $28K.
- Largest single purchase: $7.0M by RA CAPITAL MANAGEMENT, L.P. on Apr 22, 2026.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Acrivon Therapeutics, Inc. as of 2026-03-31
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | TOMSICEK MICHAEL JOHN | ACRV | Award | 20,275 | $0.00 | $0K |
| Jun 17, 2026 | DiRocco Derek | ACRV | Award | 20,275 | $0.00 | $0K |
| Jun 17, 2026 | RA CAPITAL MANAGEMENT, L.P. | ACRV | Award | 20,275 | $0.00 | $0K |
| Jun 17, 2026 | Palani Santhosh | ACRV | Award | 20,275 | $0.00 | $0K |
| Jun 17, 2026 | Shacham Sharon | ACRV | Award | 20,275 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.